References
- Vermeulen A. Dehydroepiandrosterone sulfate and aging. Ann NY Acad Sci 1995; 774: 121–128
- Morley J E, Charlton E, Patrick P, Kaiser F E, Cadeu P, McCready D. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000; 49: 1239–1242
- Moore C, Huebler D, Zimmermann T, Hineman L AJ, Saad F, Thai D M. The Aging Male Symptom Scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 2004; 46: 80–87
- Carani C, Isidori A M, Granata A, Carosa E, Maggi M, Lenzi A, Jannini E A. Multicenter study of the prevalence of sexual symptoms in male hypo and hyperthyroid patients. J Clin Endocrinol Metab 2005; 90: 90–94
- Vance M L. Can growth hormone prevent aging?. N Engl J Med 2003; 480: 779–781
- Heinemann L AJ, Zimmerman T, Vermeulen A, Theil C, Hummel W. A new ‘aging males’ symptom rating scale. Aging Male 1999; 2: 103–114
- Morley J E, Patrick P, Perry H M, III. Evaluation of assays available to measure free testosterone. Metabolism 2002; 51: 554–559
- Tancredi A, Reginster J Y, Schleich F, Pire G, Maasen P, Luycks F, Legross J J. Interest of the Androgen Deficiency in the Aging Males (ADAM) questionnaire for the identification of hypogonadism in elderly community-swelling male volunteers. Eur J Endocrinol 2004; 151: 355–360
- Morley J E, Perry H M, II, Kevorkian R T, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006; 53: 424–429
- Tramblay R R, Gagné J -M. Can we get away from serum total testosterone in the diagnosis of andropause?. Aging Male 2005; 8: 147–150
- Black A, Day A G, Morales A. The reliability of the clinical and biochemical assessment in symptomatic late onset hypogonadism. Can a case be made for a 3 month therapeutic trial?. Brit J Urol 2004; 94: 1066–1070
- Morales A J, Nolan J J, Nelson J C, Yen S SC. Effect of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360–1357
- Kawano H, Yasue H, Kitagawa A, Hirai N, Yoshida T, Soejima H, Miyamoto S, Nakano M, Ogawa H. Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab 2003; 88: 3190–3195
- Skolnick A A. Scientific verdict still out on DHEA. JAMA 1996; 276: 1365–1369
- Baulieu E -E, Thomas G, Legarin S, Lahlou N, Roger M, Debuire B, Fauconau V, Girard L, Hervey M -O, Latour F, Leaud M -C, Mokrane A, Pihi-Ferrandi H, Trivalle C, de a Charriere O, Nouveau S, Rokoto-Arison B, Souberbielle J -C, Raion J, LeBouc Y, Reyneaud A, Girerd X, Forette F. DHEA, DHEA sulfate and aging: Contribution of the DHEA age study to a sociobiomedical issue. Proc Natl Acad Sci USA 2000; 97: 4279–4284
- Labrie F, Belanger A, Simard J, Luu-Thee V, Labrie C. DHEA and peripheral androgen and estrogen formation: intracrinology. Ann NY Acad Sci 1995; 774: 16–28
- Simoncini T, Manella P, Fornari L, Varone G, Caruso A, Genazzani A R. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and non-genomic mechanisms. Endocrinology 2003; 144: 3449–3455
- Blevins L S. Beneficial effects of growth hormone replacement in growth hormone-deficient adults. The Endocrinologist 2002; 12: 405–411
- Colao A, Di Somma C, Spiezia S, Fillipella M, Pironella R, Lombardi G. Effect of Growth Hormone and/or testosterone replacement on the prostate of GH-deficient adult patients. J Clin Endocrinol Metab 2003; 88: 88–94